Esperance Pharmaceuticals, Inc.
PrivateCompany Overview
Esperance Pharmaceuticals, Inc. is a biotechnology company that develops targeted anti-cancer drugs using its proprietary cationic lytic peptide (CLYP) technology platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Esperance Pharmaceuticals, Inc. Comparables
Compare Esperance Pharmaceuticals, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| A28 Therapeutics | 88% | |
| Cybrexa Therapeutics | 79% | |
| Oncolyze, Inc. | 77% |
Esperance Pharmaceuticals, Inc. Funding Rounds
Historical fundraising activity
Esperance Pharmaceuticals, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Esperance Pharmaceuticals, Inc.'s valuation, stock price, and market status.
Is Esperance Pharmaceuticals, Inc. a public or private company?
Esperance Pharmaceuticals, Inc. is a private company.
What is the current stock price of Esperance Pharmaceuticals, Inc.?
Esperance Pharmaceuticals, Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is Esperance Pharmaceuticals, Inc. worth (valuation)?
Valuation information for Esperance Pharmaceuticals, Inc. is not publicly available.
Can I buy Esperance Pharmaceuticals, Inc. stock?
Esperance Pharmaceuticals, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Esperance Pharmaceuticals, Inc.'s last funding round?
Funding round information for Esperance Pharmaceuticals, Inc. is not publicly available.
Who are the main investors in Esperance Pharmaceuticals, Inc.?
Investor information for Esperance Pharmaceuticals, Inc. is not publicly disclosed.
Will Esperance Pharmaceuticals, Inc. IPO soon?
No public IPO plans have been announced for Esperance Pharmaceuticals, Inc..
How can I track Esperance Pharmaceuticals, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Esperance Pharmaceuticals, Inc.'s secondary market activity and sign up for updates.